About 185,000 results
Open links in new tab
BioAge Labs Announces Pricing of Upsized Initial Public Offering
BioAge stock rallies 29% following upsized $198M IPO
Weight-loss drug developer BioAge raises $198 mln in U.S. IPO
BioAge Labs Announces Pricing of Upsized Initial Public Offering
BioAge Labs IPO: stock price today in high-profile Nasdaq debut
BioAge Labs, A New Obesity Treatment Name, Rockets On Upsized IPO …
BioAge brings in $198M from IPO as obesity biotech joins Nasdaq
BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rises On …
BioAge prices $198M IPO, validating pivot to obesity drug research
Weight loss drug maker BioAge Labs eyes $200 million IPO - Quartz
- Some results have been removed